Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation

Digestive and Liver Disease

Volumn 34, Issue , 2002, Pages S160-S163

  Trinchieri, A ^a   Lizzano, R ^a   Bernardini, P ^a   Nicola, M ^a   Pozzoni, F ^a   Romano, A L ^a   Serrago, M P ^a   Confalonieri, S ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Grapefruit juice; Renal stones; Urinary excretion of citrate

Indexed keywords

CALCIUM; CALCIUM DERIVATIVE; CALCIUM OXALATE; CITRATE POTASSIUM; CITRIC ACID; MAGNESIUM; MINERAL WATER; SUGAR;

ADULT; ARTICLE; CALCIUM EXCRETION; CALCIUM OXALATE STONE; CALCIUM STONE; CARBONATED BEVERAGE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG TOLERABILITY; FEMALE; FLUID INTAKE; GRAPEFRUIT JUICE; HUMAN; HUMAN EXPERIMENT; MAGNESIUM EXCRETION; MALE; NEPHROLITHIASIS; NORMAL HUMAN; RISK FACTOR; STONE FORMATION; URINALYSIS; URINARY EXCRETION; URINE FLOW RATE;

ADULT; BEVERAGES; CALCIUM; CALCIUM OXALATE; CITRIC ACID; CITRUS PARADISI; FEMALE; HUMANS; KIDNEY CALCULI; MAGNESIUM; MALE; RISK FACTORS;

EID: 0036741397     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80186-4     Document Type: Article

References (16)

1. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-40.
2. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
3. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996;157:907-9.
4. Wabner CL, Pak CYC. Effect of orange juice consumption on urinary risk factors. J Urol 1993;149:1405-8.
5. Goldfarb DS, Asplin JR. Effect of grapefruit on urinary lithogenicity. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM, eds. Urolithiasis 2000, Cape Town: University of Cape Town 2000:317-8.
6. Marangella M, Daniele SG, Ronzani M, Sonego S, Linari F. Urine saturation with calcium salts in normal subjects and idiopathic calcium stone formers. Urol Res 1985;13:189-93.
7. Trinchieri A. Epidemiology of urolithiasis. Arch It Urol 1996;68:203-49.
8. Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F. Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis. Clin Sci 1996;91:313-8.
9. Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 1998;159:658-63.
10. Sakhaee K, Nicar M, Hill K, Pak CYC. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone forming salts. Kidney Int 1983;24:348-53.
11. Pak CYC, Fuller C, Sakhaee K, Preminger GM, Britton F. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 1985;134:11-9.
12. Preminger GM, Sakhaee K, Pak CYC. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol 1988;139:240-5.
13. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761-4.
14. Schwille PO, Herrmann U, Wolf C, Berger I, Meister R. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients. Urol Res 1992;20:145-55.
15. Hofbauer J, Hobarth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br J Urol 1994;73:362-7.
16. Roepe PD. What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance? Curr Pharmac Design 2000;6:241-60.